These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15028603)

  • 1. Atypical [(3)H]clonidine binding sites in human caudate and platelets on cryostat-cut sections.
    Zhu H; Halaris A; Piletz JE
    Ann N Y Acad Sci; 2003 Dec; 1009():296-301. PubMed ID: 15028603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.
    Gargalidis-Moudanos C; Parini A
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S59-62. PubMed ID: 8642808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoradiographic comparison of [3H]-clonidine binding to non-adrenergic sites and alpha(2)-adrenergic receptors in human brain.
    Piletz JE; Ordway GA; Zhu H; Duncan BJ; Halaris A
    Neuropsychopharmacology; 2000 Dec; 23(6):697-708. PubMed ID: 11063925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
    Molderings GJ; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes.
    Piletz JE; Zhu H; Chikkala DN
    J Pharmacol Exp Ther; 1996 Nov; 279(2):694-702. PubMed ID: 8930173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonadrenergic imidazoline binding sites on human platelets.
    Piletz JE; Sletten K
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1493-502. PubMed ID: 8263811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of [(3)H]idazoxan binding sites on human platelets.
    Ruiz J; Barinagarrementeria G; Martín-Gómez JI; Callado LF; Meana JJ
    Platelets; 2002 Jun; 13(4):241-6. PubMed ID: 12189026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of alpha2-adrenoceptor vs. imidazoline binding sites in postmortem orbitofrontal cortex and amygdala of depressed subjects.
    Piletz JE; Ordway GA; Rajkowska G; Zhu H; Klimek V; Swilley S; Duncan BJ; May W; Halaris AE
    J Psychiatr Res; 2003; 37(5):399-409. PubMed ID: 12849932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of nonadrenergic [3H]rilmenidine binding in rat brain and kidney.
    King PR; Suzuki S; Louis WJ; Gundlach AL
    Ann N Y Acad Sci; 1995 Jul; 763():194-207. PubMed ID: 7677331
    [No Abstract]   [Full Text] [Related]  

  • 10. Endogenous beta-carbolines as clonidine-displacing substances.
    Robinson ES; Anderson NJ; Crosby J; Nutt DJ; Hudson AL
    Ann N Y Acad Sci; 2003 Dec; 1009():157-66. PubMed ID: 15028582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased imidazoline and alpha 2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes.
    Halbreich U; Piletz JE; Carson S; Halaris A; Rojansky N
    Biol Psychiatry; 1993 Nov; 34(10):676-86. PubMed ID: 7904832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imidazoline receptors and their endogenous ligands.
    Regunathan S; Reis DJ
    Annu Rev Pharmacol Toxicol; 1996; 36():511-44. PubMed ID: 8725400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative autoradiographic localization in rat brain of alpha 2-adrenergic and non-adrenergic I-receptor binding sites labelled by [3H]rilmenidine.
    King PR; Gundlach AL; Louis WJ
    Brain Res; 1995 Mar; 675(1-2):264-78. PubMed ID: 7796138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet I1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder.
    Piletz JE; Halaris A; Nelson J; Qu Y; Bari M
    J Psychiatr Res; 1996; 30(3):147-68. PubMed ID: 8884655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
    Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imidazoline binding sites on PC12 cells and bovine chromaffin cells.
    Steffen G; Dendorfer A; Dominiak P
    Ann N Y Acad Sci; 1995 Jul; 763():157-62. PubMed ID: 7677325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors.
    Piletz JE; Chikkala DN; Ernsberger P
    J Pharmacol Exp Ther; 1995 Feb; 272(2):581-7. PubMed ID: 7853171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry.
    Neubig RR; Gantzos RD; Brasier RS
    Mol Pharmacol; 1985 Nov; 28(5):475-86. PubMed ID: 2865672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha 2 adrenoceptor- and imidazoline-preferring binding sites in the dog kidney.
    Evans RG; Haynes JM
    Ann N Y Acad Sci; 1995 Jul; 763():357-60. PubMed ID: 7677347
    [No Abstract]   [Full Text] [Related]  

  • 20. [3H]cirazoline as a tool for the characterization of imidazoline sites.
    Angel I; Le Rouzic M; Pimoule C; Graham D; Arbilla S
    Ann N Y Acad Sci; 1995 Jul; 763():112-24. PubMed ID: 7677320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.